Respiratory Medicine, The Prince Charles Hospital, Brisbane, Queensland, Australia.
School of Medicine, Griffith University, Gold Coast, Queensland, Australia.
Intern Med J. 2021 Sep;51(9):1526-1529. doi: 10.1111/imj.15483.
There are no published data on Australian adult cystic fibrosis (CF) patient outcomes post bronchial arterial embolisation (BAE). We report 20 years of experience of BAE at a major Australian tertiary adult CF centre, where 46 patients underwent 100 BAE during this period. Mortality rate was comparable to previous studies (4% per year) and most who died had repeat BAE requirements. A higher proportion (9 out of 45) of patients were transplanted compared to previous publications. Repeat BAE was common and significantly higher in patients already on tranexamic acid.
目前尚无关于澳大利亚成人囊性纤维化（CF）患者支气管动脉栓塞（BAE）后结局的公开数据。我们报告了一家主要的澳大利亚成人 CF 中心 20 年来的 BAE 经验，在此期间，46 名患者接受了 100 次 BAE。死亡率与先前的研究相似（每年 4%），大多数死亡患者需要重复 BAE。与之前的出版物相比，更多的患者（45 例中有 9 例）接受了移植。已经使用氨甲环酸的患者重复 BAE 更为常见，且明显更高。
